Literature DB >> 12240882

Barriers to antiretroviral adherence among HIV-infected adults.

D A Murphy1, K J Roberts, D J Martin, W Marelich, D Hoffman.   

Abstract

Success of highly active antiretroviral therapies (HAART) relies on HIV-infected patients being able to adhere to complicated treatment regimens for extremely long periods of time. Four focus groups with patients taking antiretrovirals (N = 39) were conducted to: (1) determine what strategies facilitate successful adherence; (2) determine what barriers prevent adherence; and (3) investigate the health-care provider and patient relationship and how it may impact adherence. Quantitative and qualitative information was gathered. Participants were prescribed an average of 15 pills per day (M = 14.7, SD = 6.3, range 4 to 36). Findings from the quantitative data revealed that the three strategies used most often to aid adherence were: carrying special containers for medication; having a health-care provider explain or clarify medication requirements; and carrying food and water for adherence to special instructions. The most difficult barriers for patients were sleeping through dose time, problems in following special instructions, and changes in daily routines. From the qualitative data, four main categories of barriers and aids to adherence emerged: patient characteristics, the health-care provider-patient relationship, the health-care system, and issues related to the medication regimen. Barriers related to the health care provider-patient relationship included patient satisfaction with their provider, as well as quality of communication with the provider. In addition, health-care system barriers caused difficulty in maintaining adherence. Implications for patient as well as provider interventions are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 12240882     DOI: 10.1089/108729100318127

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  45 in total

1.  A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART.

Authors:  Carol E Golin; Joanne Earp; Hsiao-Chuan Tien; Paul Stewart; Carol Porter; Lynn Howie
Journal:  J Acquir Immune Defic Syndr       Date:  2006-05       Impact factor: 3.731

Review 2.  How qualitative methods contribute to understanding combination antiretroviral therapy adherence.

Authors:  Andrea Sankar; Carol Golin; Jane M Simoni; Mark Luborsky; Cynthia Pearson
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

3.  Associations among correlates of schedule adherence to antiretroviral therapy (ART): a path analysis of a sample of crack cocaine using sexually active African-Americans with HIV infection.

Authors:  J S Atkinson; L Nilsson Schönnesson; M L Williams; S C Timpson
Journal:  AIDS Care       Date:  2008-02

Review 4.  The impact of medication regimen factors on adherence to chronic treatment: a review of literature.

Authors:  Karen S Ingersoll; Jessye Cohen
Journal:  J Behav Med       Date:  2008-01-19

5.  Latinos and HIV/AIDS: examining factors related to disparity and identifying opportunities for psychosocial intervention research.

Authors:  Jeffrey S Gonzalez; Ellen Setsuko Hendriksen; Erin Marie Collins; Ron E Durán; Steven A Safren
Journal:  AIDS Behav       Date:  2008-05-23

Review 6.  Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.

Authors:  Carol W Holtzman; Judy A Shea; Karen Glanz; Lisa M Jacobs; Robert Gross; Janet Hines; Karam Mounzer; Rafik Samuel; Joshua P Metlay; Baligh R Yehia
Journal:  AIDS Care       Date:  2015-02-11

7.  What is a missed dose? Implications for construct validity and patient adherence.

Authors:  A P Sankar; D C Nevedal; S Neufeld; M R Luborsky
Journal:  AIDS Care       Date:  2007-07

Review 8.  Latinos in the United States on the HIV/AIDS care continuum by birth country/region: a systematic review of the literature.

Authors:  Diana M Sheehan; Mary Jo Trepka; Frank R Dillon
Journal:  Int J STD AIDS       Date:  2014-05-08       Impact factor: 1.359

9.  Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco.

Authors:  Hailey J Gilmore; Albert Liu; Kimberly Ann Koester; K Rivet Amico; Vanessa McMahan; Pedro Goicochea; Lorena Vargas; David Lubensky; Susan Buchbinder; Robert Grant
Journal:  AIDS Patient Care STDS       Date:  2013-10       Impact factor: 5.078

10.  Financial obligations and economic barriers to antiretroviral therapy experienced by HIV-positive women who participated in a job-creation programme in northern Uganda.

Authors:  Kathryn Dovel; Kallie Thomson
Journal:  Cult Health Sex       Date:  2015-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.